Aoife O'Donovan1, Linda L Chao2, Jennifer Paulson3, Kristin W Samuelson4, Judy K Shigenaga2, Carl Grunfeld2, Mike W Weiner2, Thomas C Neylan2. 1. University of California, San Francisco, CA, USA; San Francisco Veteran's Affairs Medical Center and Northern California Institute for Research and Education, San Francisco, CA, USA. Electronic address: Aoife.ODonovan@ucsf.edu. 2. University of California, San Francisco, CA, USA; San Francisco Veteran's Affairs Medical Center and Northern California Institute for Research and Education, San Francisco, CA, USA. 3. University of California, San Francisco, CA, USA; San Francisco Veteran's Affairs Medical Center and Northern California Institute for Research and Education, San Francisco, CA, USA; California School of Professional Psychology at Alliant International University, USA. 4. San Francisco Veteran's Affairs Medical Center and Northern California Institute for Research and Education, San Francisco, CA, USA; California School of Professional Psychology at Alliant International University, USA.
Abstract
BACKGROUND: Inflammation may reduce hippocampal volume by blocking neurogenesis and promoting neurodegeneration. Posttraumatic stress disorder (PTSD) has been linked with both elevated inflammation and reduced hippocampal volume. However, few studies have examined associations between inflammatory markers and hippocampal volume, and none have examined these associations in the context of PTSD. METHODS: We measured levels of the inflammatory markers interleukin-6 (IL-6) and soluble receptor II for tumor necrosis factor (sTNF-RII) as well as hippocampal volume in 246 Gulf War veterans with and without current and past PTSD as assessed with the Clinician Administered PTSD Scale (CAPS). Enzyme-linked immunosorbent assays were used to measure inflammatory markers, and 1.5Tesla magnetic resonance imaging (MRI) and Freesurfer version 4.5 were used to quantify hippocampal volume. Hierarchical linear regression and analysis of covariance models were used to examine if hippocampal volume and PTSD status would be associated with elevated levels of IL-6 and sTNF-RII. RESULTS: Increased sTNF-RII, but not IL-6, was significantly associated with reduced hippocampal volume (β=-0.14, p=0.01). The relationship between sTNF-RII and hippocampal volume was independent of potential confounds and covariates, including PTSD status. Although we observed no PTSD diagnosis-related differences in either IL-6 or sTNF-RII, higher PTSD severity was associated with significantly increased sTNF-RII (β=0.24, p=0.04) and reduced IL-6 levels (β=-0.24, p=0.04). CONCLUSIONS: Our results indicate that specific inflammatory proteins may be associated with brain structure and function as indexed by hippocampal volume and PTSD symptoms.
BACKGROUND:Inflammation may reduce hippocampal volume by blocking neurogenesis and promoting neurodegeneration. Posttraumatic stress disorder (PTSD) has been linked with both elevated inflammation and reduced hippocampal volume. However, few studies have examined associations between inflammatory markers and hippocampal volume, and none have examined these associations in the context of PTSD. METHODS: We measured levels of the inflammatory markers interleukin-6 (IL-6) and soluble receptor II for tumor necrosis factor (sTNF-RII) as well as hippocampal volume in 246 Gulf War veterans with and without current and past PTSD as assessed with the Clinician Administered PTSD Scale (CAPS). Enzyme-linked immunosorbent assays were used to measure inflammatory markers, and 1.5Tesla magnetic resonance imaging (MRI) and Freesurfer version 4.5 were used to quantify hippocampal volume. Hierarchical linear regression and analysis of covariance models were used to examine if hippocampal volume and PTSD status would be associated with elevated levels of IL-6 and sTNF-RII. RESULTS: Increased sTNF-RII, but not IL-6, was significantly associated with reduced hippocampal volume (β=-0.14, p=0.01). The relationship between sTNF-RII and hippocampal volume was independent of potential confounds and covariates, including PTSD status. Although we observed no PTSD diagnosis-related differences in either IL-6 or sTNF-RII, higher PTSD severity was associated with significantly increased sTNF-RII (β=0.24, p=0.04) and reduced IL-6 levels (β=-0.24, p=0.04). CONCLUSIONS: Our results indicate that specific inflammatory proteins may be associated with brain structure and function as indexed by hippocampal volume and PTSD symptoms.
Authors: Brigitte A Apfel; Jessica Ross; Jennifer Hlavin; Dieter J Meyerhoff; Thomas J Metzler; Charles R Marmar; Michael W Weiner; Norbert Schuff; Thomas C Neylan Journal: Biol Psychiatry Date: 2010-11-20 Impact factor: 13.382
Authors: Niccolò Terrando; Claudia Monaco; Daqing Ma; Brian M J Foxwell; Marc Feldmann; Mervyn Maze Journal: Proc Natl Acad Sci U S A Date: 2010-11-01 Impact factor: 11.205
Authors: K Fukuda; R Nisenbaum; G Stewart; W W Thompson; L Robin; R M Washko; D L Noah; D H Barrett; B Randall; B L Herwaldt; A C Mawle; W C Reeves Journal: JAMA Date: 1998-09-16 Impact factor: 56.272
Authors: Zhen Wang; Thomas C Neylan; Susanne G Mueller; Maryann Lenoci; Diana Truran; Charles R Marmar; Michael W Weiner; Norbert Schuff Journal: Arch Gen Psychiatry Date: 2010-03
Authors: Ofra Ben Menachem-Zidon; Inbal Goshen; Tirzah Kreisel; Yair Ben Menahem; Etti Reinhartz; Tamir Ben Hur; Raz Yirmiya Journal: Neuropsychopharmacology Date: 2007-11-07 Impact factor: 7.853
Authors: Satish A Eraly; Caroline M Nievergelt; Adam X Maihofer; Donald A Barkauskas; Nilima Biswas; Agorastos Agorastos; Daniel T O'Connor; Dewleen G Baker Journal: JAMA Psychiatry Date: 2014-04 Impact factor: 21.596
Authors: Carsten Spitzer; Sven Barnow; Henry Völzke; Henri Wallaschofski; Ulrich John; Harald J Freyberger; Bernd Löwe; Hans Joergen Grabe Journal: J Psychiatr Res Date: 2009-07-22 Impact factor: 4.791
Authors: Charles L Raison; Robin E Rutherford; Bobbi J Woolwine; Chen Shuo; Pamela Schettler; Daniel F Drake; Ebrahim Haroon; Andrew H Miller Journal: JAMA Psychiatry Date: 2013-01 Impact factor: 21.596
Authors: T Frodl; A Carballedo; M M Hughes; K Saleh; A Fagan; N Skokauskas; D M McLoughlin; J Meaney; V O'Keane; T J Connor Journal: Transl Psychiatry Date: 2012-03-13 Impact factor: 6.222
Authors: S K Fineberg; J Leavitt; S Deutsch-Link; S Dealy; C D Landry; K Pirruccio; S Shea; S Trent; G Cecchi; P R Corlett Journal: Psychol Med Date: 2016-06-29 Impact factor: 7.723
Authors: Aoife O'Donovan; Ashkan J Ahmadian; Thomas C Neylan; Mark A Pacult; Donald Edmondson; Beth E Cohen Journal: Brain Behav Immun Date: 2016-10-17 Impact factor: 7.217
Authors: Zeynab Alshelh; Daniel S Albrecht; Courtney Bergan; Oluwaseun Akeju; Daniel J Clauw; Lisa Conboy; Robert R Edwards; Minhae Kim; Yvonne C Lee; Ekaterina Protsenko; Vitaly Napadow; Kimberly Sullivan; Marco L Loggia Journal: Brain Behav Immun Date: 2020-02-04 Impact factor: 7.217